Camden National director receives share grant

CAMDEN NATIONAL CORP director Raina Maxwell reported receiving additional company shares as compensation and through dividend reinvestment.

Accepted by SEC EDGAR 03/23/2026 - 04:22 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CAMDEN NATIONAL CORP director Raina Maxwell reported receiving additional company shares as compensation and through dividend reinvestment. On this Form 4, Maxwell acquired 317 shares of common stock at $45.26 per share as a grant under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees. A footnote also explains that 22.049 shares were accumulated since the last filing through participation in the company's dividend reinvestment program. After these transactions, Maxwell directly holds a total of 2,810.686 common shares.

Insider Trade Summary

Grant/Award: 317 shares

Grant/Award 1 txn

Insider Maxwell Raina

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	317	$45.26	$14K

Holdings After Transaction: Common Stock — 2,810.686 shares (Direct)

Footnotes (2)

1. F1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.
2. F2. Consists of 22.049 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Camden National (CAC) report for director Raina Maxwell?

Director Raina Maxwell reported acquiring Camden National common stock through a compensation-related share grant and dividend reinvestment. The filing shows a non-market award of shares in lieu of director fees plus additional shares accumulated under the company’s dividend reinvestment program, increasing direct ownership modestly.

How many Camden National (CAC) shares were granted to Raina Maxwell and at what price?

Raina Maxwell received a grant of 317 Camden National common shares valued at $45.26 per share. The filing describes this as a grant or award under the company’s 2022 Equity and Incentive Plan in lieu of director fees, not an open-market purchase transaction.

What is the source of the new Camden National (CAC) shares reported for Raina Maxwell?

The new shares came from two sources: 317 shares granted under Camden National Corporation's 2022 Equity and Incentive Plan in lieu of director fees, and 22.049 additional shares accumulated since the last filing through the company’s dividend reinvestment program, according to the footnotes.

Did Raina Maxwell buy Camden National (CAC) shares on the open market?

The reported transaction was not an open-market purchase. Instead, Maxwell received 317 shares as a compensation grant under the 2022 Equity and Incentive Plan in lieu of director fees, and additional shares accrued through the dividend reinvestment program, as detailed in the Form 4 footnotes.

How many Camden National (CAC) shares does Raina Maxwell own after this Form 4 transaction?

Following the reported transactions, Raina Maxwell directly owns 2,810.686 Camden National common shares. This total reflects the 317-share grant in lieu of director fees as well as incremental shares obtained through participation in the company’s dividend reinvestment program since the prior filing.

What compensation plan is referenced in Raina Maxwell’s Camden National (CAC) Form 4?

The Form 4 references Camden National Corporation's 2022 Equity and Incentive Plan and Amendment. Under this plan, 317 common shares were granted to director Raina Maxwell in lieu of cash director fees, aligning part of director compensation with company equity rather than cash payments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maxwell Raina

(Last) (First) (Middle)

2 ELM STREET

P.O. BOX 310

(Street)

CAMDEN MAINE 04843

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/20/2026		A		317(1)	A	$45.26	2,810.686(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

2. Consists of 22.049 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.

Remarks:

	Christopher G. Hutchinson, POA	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)